COVID-19 (SARS-CoV2 Enfeksiyonu) TEDAVİSİNDE KULLANILACAK İLAÇLARA İLİŞKİN BİLGİLENDİRME FAVİPİRAVİR 200 MG TABLE
![PDF) SARS COV2 tedavisinde favipiravir yan etkilerinin araştırılması Investigation of favipravir side effects in the treatment of SARS COV2 PDF) SARS COV2 tedavisinde favipiravir yan etkilerinin araştırılması Investigation of favipravir side effects in the treatment of SARS COV2](https://i1.rgstatic.net/publication/358235250_SARS_COV2_tedavisinde_favipiravir_yan_etkilerinin_arastirilmasi_Investigation_of_favipravir_side_effects_in_the_treatment_of_SARS_COV2/links/61f7bcea11a1090a79c3fb05/largepreview.png)
PDF) SARS COV2 tedavisinde favipiravir yan etkilerinin araştırılması Investigation of favipravir side effects in the treatment of SARS COV2
KISA ÜRÜN BİLGİSİ ▽Bu ilaç ek izlemeye tabidir. Bu üçgen yeni güvenlilik bilgisinin hızlı olarak belirlenmesini sa
COVID-19 (SARS-CoV2 Enfeksiyonu) TEDAVİSİNDE KULLANILACAK İLAÇLARA İLİŞKİN BİLGİLENDİRME FAVİPİRAVİR 200 MG TABLE
![Pharmacophore Modelling of Vanillin Derivatives, Favipiravir, Chloroquine, Hydroxychloroquine, Monolaurin and Tetrodotoxin: as MPro inhibitors of ... Pharmacophore Modelling of Vanillin Derivatives, Favipiravir, Chloroquine, Hydroxychloroquine, Monolaurin and Tetrodotoxin: as MPro inhibitors of ...](https://m.media-amazon.com/images/I/611Nz9XDS6L._AC_UF350,350_QL80_.jpg)